Albuminuria as a marker of arterial stiffness in chronic kidney disease patients

Table 2 Biochemical characteristics of the study population

Patients characteristics	Study population	Patients with moderately increased albuminuria	Patients with severely increased albuminuria	P value
No	115	58	57	-
Ht (%)	42.3 ± 3.7	43.2 ± 3.7	41.4 ± 3.5	0.01
Hb (g/dL)	13.6 ± 1.3	14.1 ± 1.5	13.3 ± 1.5	0.02
Fe (μg/dL)	89 ± 35.5	90.2 ± 30	84.2 ± 38.5	NS
Ferritin (ng/L)	127.4 ± 90.1	127.8 ± 87.9	131.3 ± 96.5	NS
Fibrinogen (mg/dL)	336 ± 82.9	339 ± 86.5	394 ± 133.9	< 0.01
hsCRP (mg/dL)	0.19 ± 0.06	0.18 ± 0.05	0.23 ± 0.10	< 0.001
T-CHOL (mg/dL)	203 ± 37.5	208 ± 39.2	209 ± 46.8	NS
TRG (mg/dL)	126 ± 45.7	123 ± 46.3	145 ± 70.2	0.05
HDL-C (mg/dL)	53.4 ± 13.3	53 ± 12.9	54.2 ± 14.9	NS
LDL-C (mg/dL)	119 ± 32	120 ± 3.7	121 ± 3.6	NS
Ca2+ (mg/dL)	9.7 ± 0.4	9.7 ± 0.5	9.8 ± 0.4	NS
PO43- (mg/dL)	3.42 ± 0.4	3.3 ± 0.4	3.5 ± 0.5	0.01
Ca2+ x PO43-	33.7 ± 4.8	32.6 ± 4.5	33.9 ± 8.6	NS
PTH (pg/mL)	42.4 ± 15.4	39.8 ± 13.6	45.4 ± 29.9	NS
sAlb (gr/dL)	4.5 ± 0.2	4.5 ± 0.3	4.3 ± 0.5	0.03
eGFR-MDRD (mL/min per 1.73 m2)
	92 ± 0.5	91.5 ± 20.5	79.1 ± 15.3	< 0.001
CKD-EPI(mL/min per 1.73 m2)
	73.4 ± 1.25	73.1 ± 13.7	73.6 ± 11.2	NS

Data are presented as mean value. Ht: Haematocrit; Hb: Haemoglobin; Fe: Serum iron; Ferritin: Serum ferritin, hsCRP: High sensitive C-reactive protein; T-CHOL: Total cholesterol; TRG: Triglycerides; HDL-C: High density lipoprotein cholesterol; Ca²⁺: Calcium; PO₄^3-: Phosphorus; PTH: Parathormone; sAlb: Serum albumin; eGFR-MDRD: Estimated-glomerular filtration rate-modification of diet in renal disease; RAAS-blocker: Renin angiotensin aldosterone system blocker; Alb: Albuminuria.